Articles by : William Newton, Associate Editor/Senior Writer

Expanding 340B Eligibility Could Double Program Size, Says Report

September 26, 2023 William Newton, Associate Editor/Senior Writer Views

An IQVIA analysis looked at the 340B program’s growth under the Affordable Care Act.

The 340B program could more than double in size if the 340B patient definition expands, according to a recent report [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Committee Rejects 340B Amendment to Bipartisan Health Bill

September 26, 2023 William Newton, Associate Editor/Senior Writer Views

Sen. Bernie Sanders, chair of the Senate HELP committee, opposed an amendment that would implement 340B hospital verification requirements.

A Senate committee rejected an effort to add new 340B hospital verification requirements as part of a sweeping healthcare funding [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Appeals Court Judges Press Both Sides in Key Hearing on Arkansas 340B Contract Pharmacy Law

September 21, 2023 William Newton, Associate Editor/Senior Writer Views

Chief Judge Lavenski Smith of the 8th Circuit Court of Appeals and two other federal judges heard highly anticipated oral arguments for PhRMA v. McClain in a case that challenges Arkansas' 340B contract pharmacy law.

Attorneys representing Arkansas and 340B providers sparred with a drug industry lawyer over the constitutionality of Arkansas’ first-in-the-nation 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Teva Ends 340B Contract Pharmacy Restrictions in Arkansas in Response to State Law

September 21, 2023 William Newton, Associate Editor/Senior Writer Views

The final HRSA manufacturer 340B program audit conducted in fiscal year 2023 had no adverse findings for Teva Pharmaceuticals.

Teva Pharmaceuticals this week ended its 340B contract pharmacy restrictions in Arkansas in response to a state law that prevents [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GOP Scrutinizes Medicare Price Negotiations in House Subcommittee Hearing

September 21, 2023 William Newton, Associate Editor/Senior Writer Views

A 340B hearing next week called by Rep. Cathy McMorris Rodgers (R-Wash.), chair of the E&C Committee, will include as witnesses a policy researcher critical of 340B and a community health center leader.

Republicans and Democrats battled over Medicare price negotiation provisions under the Inflation Reduction Act (IRA) during a contentious Sept. 20 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers Split on 340B Medicaid Provisions in Major House Healthcare Package

September 19, 2023 William Newton, Associate Editor/Senior Writer Views

Joe Dunn, senior vice president of public policy and research at NACHC, said his organization supported the Lower Costs, More Transparency Act.

Provider groups diverged over 340B Medicaid managed care provisions in a sweeping healthcare package on which the House of Representatives [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Uncertain Outlook for GOP Drug Shortages Bill with 340B Provisions

September 19, 2023 William Newton, Associate Editor/Senior Writer Views

Rep. Anna Eshoo, ranking member of the E&C Health Subcommittee, was one of multiple Democrats opposed to a Republican drug shortages bill.

The future of a Republican drug shortages bill with 340B provisions remains unclear after it was examined in a contentious [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

House Subcommittee Clashes Over 340B Role in Drug Shortages

September 14, 2023 William Newton, Associate Editor/Senior Writer Views

Legislation sponsored by Rep. Cathy McMorris Rodgers (R-Wash.) was the focus of a partisan clash during a Sept. 14 hearing over changes it would implement for the 340B program.

A House subcommittee hearing today exposed partisan divisions over the 340B program’s impact on generic drug shortages. The Sep. 14 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Louisiana AG Defends State 340B Contract Pharmacy Law Against Drug Industry Lawsuit

September 14, 2023 William Newton, Associate Editor/Senior Writer Views

Four hospital associations filed an amicus brief in support of Louisiana Attorney General Jeff Landry's defense of his state's contract pharmacy law.

The Louisiana attorney general recently asked a federal district judge to dismiss a drug industry lawsuit that challenges Louisiana’s 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

House Subcommittee to Examine GOP Drug Shortages Bill with 340B Provisions

September 12, 2023 William Newton, Associate Editor/Senior Writer Views

The House Energy & Commerce Health Subcommittee will review a draft drug shortages bill with 340B program implications.

A Sept. 14 House subcommittee hearing will review draft legislation, which would exclude certain generic drugs from the 340B program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live